Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For FLS
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -0.15 1.88 1.88
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -21.37 6.20 7.88
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.67 14.86 14.76
Cash -2.75 4.05 4.16
Capex 31.48 -0.10 -0.15
Free Cash Flow -72.24 0.37 1.33
Revenue -6.90 8.27 8.88
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 8.75 0.32 0.29
Operating Margin 15.22 0.11 0.09
ROA 17.58 0.01 0.01
ROE 17.45 0.04 0.03
ROIC -5.64 0.03 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of FLS is permitted for members.
5 Growth
The "Growth Entry" for the Focus of FLS is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of FLS is permitted for members.